Daiichi Sankyo, Inc., a prominent player in the global pharmaceutical industry, is headquartered in the United States, with significant operations across Europe, Asia, and other regions. Founded in 2005 through the merger of Daiichi Pharmaceutical and Sankyo Company, Limited, the company has established itself as a leader in innovative medicines, particularly in oncology, cardiovascular, and vaccine development. Daiichi Sankyo is renowned for its unique approach to drug discovery and development, leveraging advanced technologies to create targeted therapies. Its core products, including the groundbreaking cancer treatment, have positioned the company as a key competitor in the pharmaceutical market. With a commitment to improving patient outcomes, Daiichi Sankyo continues to achieve notable milestones, solidifying its reputation as a trusted name in healthcare.
We don't have data for Daiichi Sankyo, Inc., but we can show you information about their parent organization instead.
View parent company